Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for agriculture industry professionals · Wednesday, March 12, 2025 · 793,071,020 Articles · 3+ Million Readers

Walgreens Boots Alliance, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. March 31, 2025 Deadline to file Lead Plaintiff Motion

/EIN News/ -- LOS ANGELES, March 11, 2025 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses

The Portnoy Law Firm advises Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) investors of a class action representing investors that bought securities between April 2, 2020 and January 16, 2025, inclusive (the "Class Period"). Walgreens investors have until March 31, 2025 to file a lead plaintiff motion.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

Walgreens operates as a healthcare, pharmacy, and retail company.

The Walgreens class action lawsuit alleges that, during the Class Period, defendants made false or misleading statements and failed to disclose that:
(i) Despite Walgreens’ stated commitment to regulatory compliance, the company continued to violate federal laws governing prescription medication dispensation and reimbursement.
(ii) These violations, once revealed, exposed Walgreens to increased regulatory scrutiny, civil liability, and reputational harm.
(iii) Walgreens’ prescription medication revenues were unsustainable, as they were partially derived from unlawful practices.

The lawsuit further alleges that on January 17, 2025, the U.S. Department of Justice filed a civil complaint against Walgreens, stating that the company “dispensed millions of unlawful prescriptions in violation of the Controlled Substances Act (CSA) and then sought reimbursement for many of these prescriptions from various federal health care programs in violation of the False Claims Act (FCA).”

Following this news, Walgreens’ stock price dropped more than 12% over two trading sessions, according to the complaint.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com 

Attorney Advertising


Primary Logo

Powered by EIN News

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release